Stockreport

McKesson: Strategic Shift To High-Growth Oncology And Prescription Tech Signals Long Opportunity [Seeking Alpha]

McKesson Corporation  (MCK) 
Last mckesson corporation earnings: 2/4 07:00 am Check Earnings Report
US:NYSE Investor Relations: investor.mckesson.com
PDF healthcare services platform focused on Oncology & Multispecialty and Prescription Technology Solutions. MCK's upgraded long-term adjusted EPS growth target of 13%-16% [Read more]